TRYP Therapeutics Inc - ESG Rating & Company Profile powered by AI
This assessment of TRYP Therapeutics Inc incorporates information from across the internet as well as from public disclosures by TRYP Therapeutics Inc. The page contains a Q&A table about TRYP Therapeutics Inc. Other companies in the rating peer group for TRYP Therapeutics Inc are displayed below.
TRYP Therapeutics Inc in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 2.7; made up of an environmental score of 0.0, social score of 2.7 and governance score of 5.3.
2.7
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Analytik Jena AG | 8.0 | High |
| 1 | Amniotics AB (publ) | 8.0 | High |
| ... | ... | ... | |
| 109 | Rockwell Medical Inc | 2.8 | Medium |
| 109 | Zomedica Corp | 2.8 | Medium |
| 111 | TRYP Therapeutics Inc | 2.7 | Medium |
| 111 | Abera Bioscience AB | 2.7 | Medium |
| 111 | Aerami Therapeutics Inc | 2.7 | Medium |
| ... | ... | ... | |
| 182 | Wesana Health Holdings Inc | 0.0 | Low |
| 182 | rEVO Biologics Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does TRYP Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes TRYP Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes TRYP Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes TRYP Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes TRYP Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes TRYP Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes TRYP Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes TRYP Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid TRYP Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes TRYP Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas TRYP Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes TRYP Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes TRYP Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs TRYP Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes TRYP Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes TRYP Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes TRYP Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for TRYP Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Tryp Therapeutics Inc., a pharmaceutical company, focuses on identifying and developing compounds for diseases with high unmet medical needs. The company's lead development program is (PFN), which is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. Its PFN program candidates include TRP-8802 and TRP-8803 for fibromyalgia, phantom limb pain, binge eating disorder, complex regional pain syndrome, and hypothalamic obesity. The company has an agreement with the Calvert Labs to design and execute exploratory studies related to psilocybin-for-neuropsychiatric disorders program; and a service agreement with Fluence to provide design and training for the psychotherapeutic portion of Tryp's clinical trial activities. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. The company was incorporated in 2019 and is based in Kelowna, Canada.